alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2015023EN.01001701.xml

| 29.1.2015 | EN | Official Journal of the European Union | L 23/17 |
| --- | --- | --- | --- |

29.1.2015

EN

Official Journal of the European Union

L 23/17

---

COUNCIL DECISION (EU) 2015/137

of 26 January 2015

renewing the terms of office of the Vice-President of the Office for Harmonization in the Internal Market (Trade Marks and Designs) and of two Chairmen of the Boards of Appeal of the Office for Harmonization in the Internal Market (Trade Marks and Designs)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 207/2009 of 26 February 2009 on the Community trade mark (1), and in particular Article 125 and Article 136 thereof,

Whereas:

| (1) | On 18 November 2014, the Administrative Board of the Office for Harmonization in the Internal Market (Trade Marks and Designs) ('the Office') submitted to the Council its proposals concerning the renewal of the terms of office of the Vice-President of the Office and of two Chairmen of the Boards of Appeal of the Office. |
| --- | --- |

(1)

On 18 November 2014, the Administrative Board of the Office for Harmonization in the Internal Market (Trade Marks and Designs) ('the Office') submitted to the Council its proposals concerning the renewal of the terms of office of the Vice-President of the Office and of two Chairmen of the Boards of Appeal of the Office.

| (2) | The terms of office of Mr Christian ARCHAMBEAU as Vice-President of the Office and of Mr Tomás DE LAS HERAS and Mr Detlef SCHENNEN as Chairmen of the Boards of Appeal of the Office should be renewed for a period of five years or until retirement age if retirement age is reached during the new term of office, |
| --- | --- |

(2)

The terms of office of Mr Christian ARCHAMBEAU as Vice-President of the Office and of Mr Tomás DE LAS HERAS and Mr Detlef SCHENNEN as Chairmen of the Boards of Appeal of the Office should be renewed for a period of five years or until retirement age if retirement age is reached during the new term of office,

HAS ADOPTED THIS DECISION:

Article 1

The term of office of Mr Christian ARCHAMBEAU as Vice-President of the Office is hereby renewed for the period from 1 December 2015 to 30 November 2020 or until retirement age if retirement age is reached during the new term of office.

Article 2

The term of office of Mr Tomás DE LAS HERAS as Chairman of the Boards of Appeal of the Office is hereby renewed for the period from 1 March 2016 to 28 February 2021 or until retirement age if retirement age is reached during the new term of office.

Article 3

The term of office of Mr Detlef SCHENNEN as Chairman of the Boards of Appeal of the Office is hereby renewed for the period from 1 November 2015 to 31 October 2020 or until retirement age if retirement age is reached during the new term of office.

Article 4

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 26 January 2015.

For the Council

The President

J. DŪKLAVS

---

(1)  
  OJ L 78, 24.3.2009, p. 1.

1

---
EXHIBIT 32.2




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of El Capitan Precious Metals, Inc. (the “Company”) on Form 10-K for the fiscal year ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Stephen J. Antol, Chief Financial Officer, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.






Date:  January 13, 2011
/s/ Stephen J. AntolStephen J. AntolChief Financial Officer




A signed original of this written statement required by Section 906 has been provided to El Capitan Precious Metals, Inc. and will be retained by El Capitan Precious Metals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
<PAGE>

EXHIBIT 99.1
CERTIFICATION

Pursuant to Section 906 of the Public Company Accounting Reform and Investor
Protection Act of 2002 (18 U.S.C. Section 1350, as adopted) (the Sarbanes-Oxley
Act of 2002), Joseph D. Keegan, Ph.D., the Chief Executive Officer of Molecular
Devices Corporation (the "Company"), and Timothy A. Harkness, the Chief
Financial Officer of the Company, each hereby certifies that, to his knowledge:

1. The Company's Quarterly Report on Form 10-Q/A for the period ended March 31,
2003, to which this Certification is attached as Exhibit 99.1 (the "Periodic
Report"), fully complies with the requirements of Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition of the Company at the end of the
periods covered by the Periodic Report and results of operations of the Company
for the periods covered by the Periodic Report.

This certification accompanies the Periodic Report pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not be deemed "filed" by the Company
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

Dated: May 16, 2003


/s/ JOSEPH D. KEEGAN                            /s/ TIMOTHY A. HARKNESS
---------------------------                     ---------------------------
Joseph D. Keegan, Ph.D.                         Timothy A. Harkness
Chief Executive Officer                         Chief Financial Officer


A signed original of this written statement required by Section 906 has been
provided to Molecular Devices Corporation and will be retained by Molecular
Devices Corporation and furnished to the Securities and Exchange Commission or
its staff upon request.
#### In the Matter of Allstate Insurance Company, Respondent, v Antonia Farrauto et al., Appellants.

[631 NYS2d 541]

Appeal by Antonia and Giuseppe Farrauto from an order and judgment (one paper) of the Supreme Court, Queens County (Kassoff, J.), dated March 3, 1994.

Ordered that the order and judgment is affirmed, with costs, for reasons stated by Justice Kassoff in his memorandum decision dated March 3, 1994. Sullivan, J. P., Miller, Copertino, Joy and Friedmann, JJ., concur.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-12-00092-CR

Randall Joseph Boudreaux, Appellant

v.

The State of Texas, Appellee

FROM THE COUNTY COURT AT LAW NO. 8 OF TRAVIS COUNTY

NO. C-1-CR-09-209499, HONORABLE CARLOS HUMBERTO BARRERA, JUDGE PRESIDING

M E M O R A N D U M O P I N I O N

Appellant filed his notice of appeal on January 11, 2012, and the clerk’s record was

filed on February 13. On March 14, we sent appellant’s counsel notice that the reporter’s record was

overdue and that the court reporter had informed us that appellant had neither paid for nor made

arrangements to pay for the record. To date, the record has not been filed. On May 24, we sent

appellant’s counsel notice that the brief was overdue, requesting a response no later than June 4.

Counsel has not responded, and the brief has not been filed.

The appeal is therefore abated. The trial court shall conduct a hearing to determine

whether appellant still wishes to pursue his appeal, whether he is indigent, and whether counsel has

abandoned the appeal. See Tex. R. App. P. 38.8(b). The court shall make appropriate findings and

recommendations, and a supplemental record from this hearing, including copies of all findings and
orders and a transcription of the court reporter’s notes, shall be forwarded to the clerk of this Court

no later than December 21, 2012. See id.

__________________________________________

David Puryear, Justice

Before Justices Puryear, Pemberton and Henson

Abated

Filed: November 16, 2012

Do Not Publish

2
<PAGE>
                                                                    Exhibit 31.1





                                 CERTIFICATIONS

I, Peter K. Stevenson, certify that:

     1.   I have reviewed this quarterly report on Form 10-Q of Globix
          Corporation for the period ended June 30, 2002;

     2.   Based on my knowledge, this report does not contain any untrue
          statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this report; and

     3.   Based on my knowledge, the financial statements, and other financial
          information included in this report, fairly present in all material
          respects the financial condition, results of operations and cash flows
          of the registrant as of, and for, the periods presented in this
          report.

                                        Globix Corporation


Date: September 8, 2003                 /s/ Peter K. Stevenson
                                        ----------------------------------------
                                        Peter K. Stevenson
                                        President and Chief Executive Officer
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before February 25, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before February 25, 2015.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of importers, of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on June 16, 2014, Fisher Clinical Services, Inc. 7554 Schantz Road, Allentown, Pennsylvania 18106 applied to be registered as an importer of the following basic classes of controlled substances:
                    ( print page 3980) Controlled substance
ScheduleMethylphenidate (1724)
IILevorphanol (9220)
IINoroxymorphone (9668)
IITapentadol (9780)
II
 The company plans to import the listed substances for analytical research, testing, and clinical trials. This authorization does not extend to the import of a finished FDA approved or non-approved dosage form for commercial distribution in the United States. The company plans to import an intermediate form of tapentadol (9780) to bulk manufacture tapentadol for distribution to its customers. Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-01309 Filed 1-23-15; 8:45 am] BILLING CODE P
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Prepared by NRC Staff

# Safety Evaluation Report Related to the License Renewal of Cooper Nuclear Station (NUREG-1944)

On this page:
        - Publication Information 
        - Abstract

Download complete document
        - NUREG-1944 (PDF - 42.49 MB)

## Publication Information

**Manuscript Completed:** October 2010**Date Published:** October 2010

Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

Availability Notice

## Abstract

This safety evaluation report (SER) documents the technical review of the Cooper Nuclear Station (CNS) license renewal application (LRA) by the U.S. Nuclear Regulatory Commission (NRC) staff (the staff). By letter dated September 24, 2008, Nebraska Public Power District (NPPD or the applicant) submitted the LRA in accordance with Title 10, Part 54, of the *Code of Federal Regulations*, "Requirements for Renewal of Operating Licenses for Nuclear Power Plants." NPPD requests renewal of the CNS operating license (Facility Operating License Number DPR-46) for a period of 20 years beyond the current expiration at midnight January 18, 2014. CNS is located in Nemaha County, Nebraska, on the west bank of the Missouri River at river mile 532.5. The NRC issued the construction permit for CNS in June 1968 and operating license on January 18, 1974. CNS is a boiling-water reactor (BWR) design. General Electric supplied the nuclear steam supply system and Burns and Roe originally designed and constructed the balance of the plant. The CNS licensed power output is 2,419 megawatt thermal (MWt) with a gross electrical output of approximately 830 megawatt electric (MWe). The staff identified open items that must be resolved before any final determination can be made on the LRA. SER Section 1.5 summarizes these items and their resolutions. With the resolution of open items and on the basis of its review, the staff concludes that the requirements for license renewal have been met.

Page Last Reviewed/Updated Tuesday, March 09, 2021
No. 90-6080.

#### Huckaby *v.*Oklahoma et al.

Ct. Crim. App. Okla. Certiorari denied.
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Resulting from International Agreements

# Assessment of TRACE5.0 Code Against ATLAS Test A5.2. Counterpart Test to LSTF (NUREG/IA-0540)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/IA-0540 (PDF – 1.53 MB)

## Publication Information

**Manuscript Completed:** January 2023**Date Published:** August 2023

**Prepared by:**M.Lorduy, S. Gallardo and G. Verdú

Universitat Politècnica de ValènciaInstituto Universitario de Seguridad Industrial, Radiofísica y MedioambientalCamí de Vera s/n46022 València, Spain

K.Tien, NRC Project Manager

Division of Systems AnalysisOffice of Nuclear Regulatory ResearchU.S. Nuclear Regulatory CommissionWashington, DC 20555-0001

**Prepared as part of:**The Agreement on Research Participation and Technical ExchangeUnder the Thermal-Hydraulic Code Applications and Maintenance Program (CAMP)

**Published by:**U.S. Nuclear Regulatory CommissionWashington, DC 20555-0001

Availability Notice

## Abstract

The purpose of this work is to overview the results provided by the simulation of a counterpart experiment reproducing an Intermediate Break Loss-Of-Coolant Accident (IBLOCA) at the ATLAS and LSTF integral test facilities, using the thermal-hydraulic code TRACE5 patch 5 and the Symbolic Nuclear Analysis Packages software (SNAP) version 2.6.8.

The scenario simulates a 13% cold leg IBLOCA under the assumption of the full High-Pressure and Low-Pressure Injections, and the total failure of the Auxiliary Feedwater.

The simulation results are compared with the available data of the A5.2 and IB-CL-05 tests, in the OECD-ATLAS and OECD/NEA ROSA-2 projects, respectively, to evaluate the prediction capabilities of TRACE5 and clarify the causes of the major differences between the transients. Furthermore, these results represent a contribution to assess the predictability of computer codes such as TRACE5.

Page Last Reviewed/Updated Thursday, September 07, 2023
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 10-40680

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

VICTOR BLANCAS-ROSAS,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 1:10-CR-801-1

Before JOLLY, OWEN, and HAYNES, Circuit Judges.

PER CURIAM:

*

The Federal Public Defender appointed to represent Victor Blancas-Rosas

has moved for leave to withdraw and has filed a brief in accordance with Anders

v. California, 386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 (5th

Cir. 2011). Blancas-Rosas has not filed a response. We have reviewed counsel’s

brief and the relevant portions of the record reflected therein. We concur with

counsel’s assessment that the appeal presents no nonfrivolous issue for appellate

review. Accordingly, counsel’s motion for leave to withdraw is GRANTED,

United States Court of Appeals

Fifth Circuit

F I L E D

April 19, 2011

Lyle W. Cayce

Clerk

Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

Case: 10-40680 Document: 00511450295 Page: 1 Date Filed: 04/19/2011
No. 10-40680

counsel is excused from further responsibilities herein, and the APPEAL IS

DISMISSED. See 5TH CIR. R. 42.2.

2

Case: 10-40680 Document: 00511450295 Page: 2 Date Filed: 04/19/2011
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the LCA-Vision Inc.
condensed consolidated balance sheet at June 30, 1999, and the related condensed
consolidated statement of operations for the six months ended June 30, 1999, and
is qualified in its entirety by reference to such financial statement.
</LEGEND>
<CIK> 0001003130
<NAME> LCA-VISION INC.
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                              JAN-1-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           9,029
<SECURITIES>                                         0
<RECEIVABLES>                                    3,948
<ALLOWANCES>                                     1,267
<INVENTORY>                                         75
<CURRENT-ASSETS>                                15,343
<PP&E>                                          16,964
<DEPRECIATION>                                   8,255
<TOTAL-ASSETS>                                  34,485
<CURRENT-LIABILITIES>                            5,615
<BONDS>                                            496
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      2,522
<COMMON>                                           108
<OTHER-SE>                                      25,744
<TOTAL-LIABILITY-AND-EQUITY>                    34,485
<SALES>                                              0
<TOTAL-REVENUES>                                28,597
<CGS>                                                0
<TOTAL-COSTS>                                   17,489
<OTHER-EXPENSES>                                 7,509
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 120
<INCOME-PRETAX>                                  4,113
<INCOME-TAX>                                         8
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,105
<EPS-BASIC>                                       0.09
<EPS-DILUTED>                                     0.09


</TABLE>
HomeNRC LibraryDocument CollectionsNews Releases1997

# Note to Editors -- Maine Yankee Commission Briefing

----

No. 97-016

February 3, 1997

NOTE TO EDITORS 

----

-- MAINE YANKEE COMMISSION BRIEFING

The staff of the Nuclear Regulatory Commission and officials from Maine Yankee Atomic Power Co. will brief the Commission Tuesday, February 4, on the status of the Maine Yankee nuclear power plant in Wiscasset, Maine. Representatives of four other organizations also will address the Commission. The meeting, which is open to the public, will begin at 9:30 a.m. in the Commissioner's Conference Room at One White Flint, 11555 Rockville Pike, Rockville, Md.

Page Last Reviewed/Updated Wednesday, March 24, 2021
**MEMORANDUM**

**DATE:** 10/ 06 /2014 **FROM:** Laura Farris/EPA Region 8 **TO:** Clean Power Plan for Existing Power Plants; Docket Id: OAR– 2013
- 0602 **SUBJECT:** CREA Energy Innovations Summit held on 10/ 2 7 /2014 **SUMMARY :**  Shaun McGrath participated in a panel discussion on the Clean Power Plan at the Colorado Rural Electric Association ’s (CREA) Energy Innovations Summit held on October 2 7 , 2014 , in Denver, Colorado . The panel included speakers from Xcel Energy, Colorado Springs Utilities, and Tri State Generati on and Transmission . The Clean Power Plan was proposed on June 2, 2014. **ATTENDEES: EPA**  **Region 8** Shaun McGrath, EPA Region 8 Regional Administrator **E xternal Stakeholders**  Jack Ihle, Director, Environmental Policy, Xcel Energy Shaun McGrath, Administrator, Environmental Protection Agency, Region 8 David Padgett, Chief Environment, Health & Safety Officer, Colorado Springs Utilities Moderator: Barbara Walz, Senior Vice President, Pol icy & Compliance, Tri State G&T Summit attendees